Compare First Solar, Inc. (FSLR) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Solar, Inc. vs GE HealthCare Technologies Inc. Common Stock — how do they compare? First Solar, Inc. trades at $177.22 (market cap $19.25B), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while First Solar, Inc. pays none. Which is the better fit depends on your goals.
| FSLR | GEHC | |
|---|---|---|
Market Cap | $19.25B | $30.93B |
Volume | 2,086,427 | 5,033,451 |
Sector | Energy | Health |
52-Week High | $318.30 | $88.16 |
52-Week Low | $172.11 | $59.48 |
Typical Hold Time | 76 Days | — |
Enterprise Value | $17.71B | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Solar (FSLR) trades at $186.60, up 3.83% today, but remains in a bearish technical trend with resistance near $190. The company reported strong revenue growth to $5.22 billion in 2025 and a net income margin of 32.47%, though it missed Q4 2025 EPS estimates. Recent news includes a patent lawsuit against competitors and elevated put option activity, reflecting mixed sentiment amid sector-wide pressures from high borrowing costs.
FSLR presents a value opportunity with a low P/E of 11.5 and analyst consensus price target of $269, but faces risks from solar industry headwinds and technical bearish signals. Earnings beats in recent quarters support fundamentals, yet political and financing challenges could limit near-term upside.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
